Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

IgM Multiple Myeloma: Disease Definition, Prognosis, and Differentiation From Waldenstrom's Macroglobulinemia.

Steven Schuster, MD, Angela Dispenzieri, M.D., S. Vincent Rajkumar, M.D., Alvaro Moreno Aspitia, Assistant, Professor, of, Medici, Robert Kyle, M.D., Joseph R. Mikhael, MD

Blood (2009) 114 (22): 1828.

https://doi.org/10.1182/blood.V114.22.1828.1828

Published: 2009

Journal Articles

Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Prashant Kapoor, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD, Shirshendu Sinha, MBBS, Morie A. Gertz, MD, A. Keith Stewart, MD, P. Leif Bergsagel, MD, Martha Q. Lacy, MD, David Dingli, M.D., PhD., Rhett P. Ketterling, MD, Robert Kyle, M.D., Philip R. Greipp, MD, Angela Dispenzieri, MD, Shaji Kumar, MD

Blood (2009) 114 (22): 1802.

https://doi.org/10.1182/blood.V114.22.1802.1802

Published: 2009

Journal Articles

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Francis Buadi, MD, Martha Q. Lacy, MD, Angela Dispenzieri, M.D., Shaji Kumar, Suzanne Hayman, MD, Kristen E Detweiler Short, R.N., C.N.P., David Dingli, M.D., PhD., Steven R. Zeldenrust, M.D., Ph.D., Philip R. Greipp, MD, John A. Lust, MD, PhD, Stephen J. Russell, MD, PhD, Robert Kyle, M.D., Vincent Rajkumar, MD, Morie A Gertz, MD

Blood (2009) 114 (22): 4953.

https://doi.org/10.1182/blood.V114.22.4953.4953

Published: 2009

Journal Articles

Melphalan and Prednisone (MP) Versus Melphalan, Prednisone and Thalidomide (MPT) as Initial Therapy for Previously Untreated Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials.

Prashant Kapoor, MD, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD, Martha Q. Lacy, MD, David Dingli, M.D., PhD., Robert Kyle, M.D., Morie A. Gertz, MD, Philip . R Greipp, MD, Shaji Kumar, MD, Sumithra J. Mandrekar, PhD

Blood (2009) 114 (22): 615.

https://doi.org/10.1182/blood.V114.22.615.615

Published: 2009

Journal Articles

The Biologic and Analytic Variability of Serum Protein Electrophoresis M-Spike, Nephelometric Ig Quantitation, Serum FLC Quantitation, and Urine M-Spike in Monoclonal Gammopathies.

Melissa Snyder, Angela Dispenzieri, M.D., S.Vincent Rajkumar, M.D., Robert Kyle, M.D., Joanne Benson, BA, Jerry A. Katzmann, PhD

Blood (2009) 114 (22): 1803.

https://doi.org/10.1182/blood.V114.22.1803.1803

Published: 2009

Journal Articles

Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma.

Sergio Siragusa, MD, William Morice, MD, PhD, Morie A Gertz, MD, Robert Kyle, M.D., Philip R. Greipp, MD, John A. Lust, MD, PhD, Thomas E Witzig, MD, Martha Q. Lacy, MD, Steven R. Zeldenrust, M.D.,Ph.D., S. Vincent Rajkumar, MD, Suzanne R. Hayman, MD, Francis Buadi, Stephen J. Russell, MD, PhD, Shaji Kumar, MD, David Dingli, M.D., PhD., Angela Dispenzieri

Blood (2009) 114 (22): 2803.

https://doi.org/10.1182/blood.V114.22.2803.2803

Published: 2009

Journal Articles

Associations of DNA Repair Gene Polymorphisms in XRCC1 and ERCC2 with Clinical Outcome in ECOG Trial E9486.

Brian Van Ness, Ph.D., Emily Blood, Ph.D., Philip Greipp, M.D., Neil Kay, M.D., Vincent Rajkumar, M.D., Robert Kyle, M.D., Martin Oken, M.D., Rafael Fonseca, M.D., Fangyi Zhao, Ph.D.

Blood (2004) 104 (11): 1475.

https://doi.org/10.1182/blood.V104.11.1475.1475

Published: 2004

NARROW

IgM Multiple Myeloma: Disease Definition, Prognosis, and Differentiation From Waldenstrom's Macroglobulinemia.

Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Melphalan and Prednisone (MP) Versus Melphalan, Prednisone and Thalidomide (MPT) as Initial Therapy for Previously Untreated Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials.

The Biologic and Analytic Variability of Serum Protein Electrophoresis M-Spike, Nephelometric Ig Quantitation, Serum FLC Quantitation, and Urine M-Spike in Monoclonal Gammopathies.

Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma.

Associations of DNA Repair Gene Polymorphisms in XRCC1 and ERCC2 with Clinical Outcome in ECOG Trial E9486.

Email alerts

ASH Publications

American Society of Hematology

IgM Multiple Myeloma: Disease Definition, Prognosis, and Differentiation From Waldenstrom's Macroglobulinemia.

Evidence for Cytogenetic and Fluorescence in Situ Hybridization (FISH) Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Melphalan and Prednisone (MP) Versus Melphalan, Prednisone and Thalidomide (MPT) as Initial Therapy for Previously Untreated Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials.

The Biologic and Analytic Variability of Serum Protein Electrophoresis M-Spike, Nephelometric Ig Quantitation, Serum FLC Quantitation, and Urine M-Spike in Monoclonal Gammopathies.

Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma.

Associations of DNA Repair Gene Polymorphisms in XRCC1 and ERCC2 with Clinical Outcome in ECOG Trial E9486.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only